# Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers

> **NCT06558071** · PHASE3 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 160 (actual)

## Conditions studied

- Lactation Induced

## Interventions

- **DRUG:** Galatonol 300 mg/Striatin 30 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06558071
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-21
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-05-27
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06558071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06558071, "Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06558071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*